Aradigm Corporation (ARDM) Announces First Quarter 2013 Financial Results
5/14/2013 8:16:18 AM
More...
|
Aradigm Corporation (ARDM) Announces Fourth Quarter 2012 and Full Year Financial Results
3/26/2013 6:33:34 AM
More...
|
Aradigm Corporation (ARDM) to Present at Biotech Showcase 2013 on January 9
1/3/2013 6:26:04 AM
More...
|
Aradigm Corporation (ARDM) Announces Third Quarter 2012 Financial Results
11/8/2012 9:59:08 AM
More...
|
Virginia Commonwealth University Scientists Report Anti-Inflammatory Effect of Aradigm Corporation (ARDM)'s Inhaled Liposomal Ciprofloxacin
10/16/2012 10:07:55 AM
More...
|
UK Scientists Report Successful Testing of Aradigm Corporation (ARDM)'s Inhaled Liposomal Ciprofloxacin in Q Fever
9/20/2012 9:28:39 AM
More...
|
New U.S. Composition of Matter Patent for Aradigm Corporation (ARDM)'s Pulmaquin™ and Lipoquin™ Provides Protection Until 2031
9/18/2012 8:41:07 AM
More...
|
Aradigm Corporation (ARDM) Patent Protection for Smoking Cessation is Extended With Issuance of a Method of Treatment Patent
9/5/2012 10:33:34 AM
More...
|
Aradigm Corporation (ARDM) to Participate in FDA Workshop on Non-Cystic Fibrosis Bronchiectasis
8/30/2012 10:05:49 AM
More...
|
Aradigm Corporation (ARDM) to Present at the Stifel Nicolaus 2012 Healthcare Conference
8/29/2012 10:08:11 AM
More...
|
|